| Diabetes Management and Research | Lifetime | 11 | IT 1 | 99.87 |
| Advanced Glycation End Products research | Lifetime | 7 | IT 1 | 99.78 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 9 | IT 1 | 99.69 |
| Diabetes Treatment and Management | Lifetime | 37 | IT 2 | 99.81 |
| Diabetes and associated disorders | Lifetime | 48 | IT 2 | 99.60 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 51 | IT 2 | 99.73 |
| Natural Antidiabetic Agents Studies | Lifetime | 31 | IT 1 | 99.51 |
| COVID-19 Clinical Research Studies | Lifetime | 138 | IT 12 | 99.21 |
| Metabolism, Diabetes, and Cancer | Lifetime | 120 | IT 7 | 99.41 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 136 | IT 3 | 99.27 |
| Diet and metabolism studies | Lifetime | 425 | IT 16 | 99.18 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 111 | IT 3 | 98.68 |
| Cardiovascular Function and Risk Factors | Lifetime | 459 | IT 25 | 99.16 |
| Pancreatic function and diabetes | Lifetime | 369 | IT 13 | 98.86 |
| Blood properties and coagulation | Lifetime | 110 | IT 7 | 98.54 |
| Nitric Oxide and Endothelin Effects | Lifetime | 286 | IT 11 | 98.68 |
| Cardiovascular Health and Disease Prevention | Lifetime | 309 | IT 21 | 98.46 |
| Diet, Metabolism, and Disease | Lifetime | 324 | IT 23 | 98.27 |
| Biochemical effects in animals | Lifetime | 274 | IT 10 | 97.86 |
| Pharmacology and Obesity Treatment | Lifetime | 140 | IT 12 | 98.29 |
| Vitamin C and Antioxidants Research | Lifetime | 177 | IT 6 | 97.43 |
| Drug-Induced Ocular Toxicity | Lifetime | 947 | IT 29 | 64.33 |
| Diabetes Treatment and Management | 2021-2025 | 76 | IT 4 | 99.13 |
| COVID-19 Clinical Research Studies | 2021-2025 | 410 | IT 43 | 98.08 |
| Diabetes and associated disorders | 2021-2025 | 75 | IT 3 | 97.80 |
| Diabetes Management and Research | 2021-2025 | 204 | IT 11 | 97.24 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 131 | IT 10 | 95.42 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 547 | IT 71 | 96.38 |
| Pancreatic function and diabetes | 2021-2025 | 934 | IT 72 | 87.22 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 783 | IT 34 | 86.07 |